Literature DB >> 27746970

Pharmacotherapy in acute respiratory distress syndrome-the long and winding road.

Michael Mazzeffi1.   

Abstract

Entities:  

Year:  2016        PMID: 27746970      PMCID: PMC5059337          DOI: 10.21037/jtd.2016.08.35

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

2.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

3.  Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.

Authors:  Guadalupe Ortiz-Muñoz; Beñat Mallavia; Adriaan Bins; Mark Headley; Matthew F Krummel; Mark R Looney
Journal:  Blood       Date:  2014-08-20       Impact factor: 22.113

4.  Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury.

Authors:  Jochen Grommes; Jean-Eric Alard; Maik Drechsler; Sarawuth Wantha; Matthias Mörgelin; Wolfgang M Kuebler; Michael Jacobs; Philipp von Hundelshausen; Philipp Markart; Malgorzata Wygrecka; Klaus T Preissner; Tilman M Hackeng; Rory R Koenen; Christian Weber; Oliver Soehnlein
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

5.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

6.  Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

7.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.

Authors:  Mark R Looney; John X Nguyen; Yongmei Hu; Jessica A Van Ziffle; Clifford A Lowell; Michael A Matthay
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

8.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

Authors:  Jonathon D Truwit; Gordon R Bernard; Jay Steingrub; Michael A Matthay; Kathleen D Liu; Timothy E Albertson; Roy G Brower; Carl Shanholtz; Peter Rock; Ivor S Douglas; Bennett P deBoisblanc; Catherine L Hough; R Duncan Hite; B Taylor Thompson
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.

Authors:  O Eickmeier; H Seki; O Haworth; J N Hilberath; F Gao; M Uddin; R H Croze; T Carlo; M A Pfeffer; B D Levy
Journal:  Mucosal Immunol       Date:  2012-07-11       Impact factor: 7.313

View more
  1 in total

1.  Biocompatible N-acetyl-nanoconstruct alleviates lipopolysaccharide-induced acute lung injury in vivo.

Authors:  Seongchan Kim; Shin Young Kim; Seung Joon Rho; Seung Hoon Kim; So Hyang Song; Chi Hong Kim; Hyojin Lee; Sung Kyoung Kim
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.